 Dong Wang
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 2 | 2022 | 156 | 0.820 |
Why?
| | Medulloblastoma | 2 | 2022 | 198 | 0.810 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.570 |
Why?
| | Glucosides | 1 | 2018 | 38 | 0.570 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.570 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 66 | 0.550 |
Why?
| | Kidney Diseases | 2 | 2018 | 384 | 0.540 |
Why?
| | Bile Acids and Salts | 5 | 2020 | 195 | 0.480 |
Why?
| | Liver Diseases | 1 | 2018 | 290 | 0.470 |
Why?
| | Acinar Cells | 5 | 2014 | 13 | 0.450 |
Why?
| | Glioma | 4 | 2022 | 354 | 0.440 |
Why?
| | Heart | 1 | 2017 | 637 | 0.430 |
Why?
| | Kidney | 2 | 2017 | 1385 | 0.410 |
Why?
| | Myocardium | 1 | 2017 | 980 | 0.390 |
Why?
| | Zinc Fingers | 2 | 2009 | 44 | 0.370 |
Why?
| | Oryza | 2 | 2008 | 31 | 0.360 |
Why?
| | Genome, Plant | 2 | 2008 | 50 | 0.360 |
Why?
| | Pancreas | 4 | 2014 | 306 | 0.350 |
Why?
| | Arabidopsis | 2 | 2008 | 85 | 0.340 |
Why?
| | Diet, Western | 2 | 2020 | 79 | 0.300 |
Why?
| | Hypertension | 1 | 2017 | 1242 | 0.300 |
Why?
| | Biliary Atresia | 2 | 2021 | 161 | 0.290 |
Why?
| | Obesity | 2 | 2018 | 2883 | 0.280 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2017 | 217 | 0.250 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2017 | 207 | 0.240 |
Why?
| | Cell Line, Tumor | 5 | 2022 | 3215 | 0.220 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 284 | 0.220 |
Why?
| | Brain Stem Neoplasms | 2 | 2021 | 89 | 0.210 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 2 | 2014 | 71 | 0.200 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 45 | 0.190 |
Why?
| | Cell Proliferation | 4 | 2022 | 2391 | 0.190 |
Why?
| | Liver | 3 | 2020 | 1839 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 64 | 0.190 |
Why?
| | Pancreatitis | 2 | 2012 | 129 | 0.180 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2021 | 22 | 0.180 |
Why?
| | Radiation Tolerance | 1 | 2022 | 100 | 0.180 |
Why?
| | Receptor, trkC | 1 | 2021 | 10 | 0.180 |
Why?
| | Receptor, trkB | 1 | 2021 | 30 | 0.180 |
Why?
| | Rhabdoid Tumor | 1 | 2022 | 98 | 0.170 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 60 | 0.170 |
Why?
| | Quinazolines | 1 | 2022 | 244 | 0.170 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2020 | 48 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Transcriptional Elongation Factors | 1 | 2020 | 36 | 0.170 |
Why?
| | Immunoglobulin M | 1 | 2021 | 275 | 0.160 |
Why?
| | Piperazines | 1 | 2022 | 342 | 0.160 |
Why?
| | DNA Repair | 1 | 2021 | 207 | 0.160 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2017 | 182 | 0.160 |
Why?
| | Taurolithocholic Acid | 3 | 2014 | 3 | 0.150 |
Why?
| | Apoptosis | 3 | 2022 | 2503 | 0.150 |
Why?
| | Aging | 2 | 2020 | 1776 | 0.150 |
Why?
| | Pyrazoles | 1 | 2022 | 405 | 0.150 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 474 | 0.150 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 638 | 0.150 |
Why?
| | Animals | 14 | 2022 | 35361 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 586 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 67 | 0.150 |
Why?
| | Histones | 2 | 2020 | 588 | 0.150 |
Why?
| | Plant Proteins | 2 | 2009 | 89 | 0.150 |
Why?
| | Mice, Obese | 1 | 2018 | 59 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 511 | 0.140 |
Why?
| | Lipid Metabolism | 2 | 2020 | 497 | 0.140 |
Why?
| | Heart Function Tests | 1 | 2017 | 59 | 0.140 |
Why?
| | Urinalysis | 1 | 2017 | 75 | 0.140 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 109 | 0.140 |
Why?
| | Kidney Function Tests | 1 | 2017 | 152 | 0.140 |
Why?
| | Kidney Tubules | 1 | 2017 | 114 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 261 | 0.130 |
Why?
| | Calcium Signaling | 3 | 2013 | 250 | 0.130 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 280 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5440 | 0.120 |
Why?
| | Renal Insufficiency | 1 | 2017 | 149 | 0.120 |
Why?
| | Mice | 11 | 2022 | 16937 | 0.110 |
Why?
| | Oxidative Stress | 2 | 2018 | 1269 | 0.110 |
Why?
| | Electrocardiography | 1 | 2017 | 608 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 339 | 0.110 |
Why?
| | Antineoplastic Agents | 2 | 2022 | 2061 | 0.110 |
Why?
| | Genes, Plant | 3 | 2009 | 46 | 0.110 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1304 | 0.110 |
Why?
| | Weight Gain | 1 | 2018 | 510 | 0.110 |
Why?
| | Lipids | 1 | 2018 | 625 | 0.110 |
Why?
| | Cytological Techniques | 1 | 2013 | 26 | 0.110 |
Why?
| | Adenoviridae Infections | 1 | 2013 | 15 | 0.110 |
Why?
| | Autoantibodies | 1 | 2021 | 1466 | 0.100 |
Why?
| | Mutation | 2 | 2021 | 3717 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 815 | 0.100 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2012 | 31 | 0.100 |
Why?
| | Secretory Vesicles | 1 | 2012 | 25 | 0.100 |
Why?
| | Cytosol | 1 | 2012 | 218 | 0.100 |
Why?
| | Calcineurin | 1 | 2012 | 98 | 0.100 |
Why?
| | Blood Pressure | 1 | 2017 | 1736 | 0.090 |
Why?
| | Cytokines | 1 | 2018 | 2017 | 0.080 |
Why?
| | Calcium | 2 | 2014 | 1213 | 0.080 |
Why?
| | Inflammation | 2 | 2018 | 2736 | 0.080 |
Why?
| | Epigenomics | 2 | 2020 | 110 | 0.080 |
Why?
| | Child | 4 | 2022 | 20883 | 0.080 |
Why?
| | Gossypium | 1 | 2009 | 4 | 0.080 |
Why?
| | Insulin Resistance | 1 | 2018 | 1165 | 0.080 |
Why?
| | Rats | 1 | 2017 | 5500 | 0.080 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2009 | 67 | 0.080 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2008 | 67 | 0.080 |
Why?
| | RNA, Plant | 1 | 2008 | 9 | 0.070 |
Why?
| | Chromosomes, Plant | 1 | 2008 | 12 | 0.070 |
Why?
| | Blood Glucose | 1 | 2018 | 2097 | 0.070 |
Why?
| | Gene Duplication | 1 | 2008 | 67 | 0.070 |
Why?
| | Humans | 13 | 2022 | 129650 | 0.070 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 213 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 833 | 0.070 |
Why?
| | Phylogeny | 2 | 2008 | 852 | 0.070 |
Why?
| | Sequence Alignment | 1 | 2008 | 332 | 0.070 |
Why?
| | Arabidopsis Proteins | 1 | 2008 | 68 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 372 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 199 | 0.070 |
Why?
| | Male | 9 | 2021 | 63681 | 0.070 |
Why?
| | Cholesterol | 2 | 2020 | 412 | 0.070 |
Why?
| | Podocytes | 2 | 2017 | 52 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 510 | 0.070 |
Why?
| | Chromatin | 2 | 2020 | 479 | 0.070 |
Why?
| | Species Specificity | 1 | 2008 | 575 | 0.070 |
Why?
| | Biomarkers | 1 | 2017 | 3973 | 0.060 |
Why?
| | Signal Transduction | 2 | 2017 | 4925 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2009 | 413 | 0.060 |
Why?
| | Child, Preschool | 4 | 2021 | 10517 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 964 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2009 | 743 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2017 | 2708 | 0.060 |
Why?
| | RNA-Binding Proteins | 1 | 2008 | 388 | 0.060 |
Why?
| | Base Sequence | 1 | 2008 | 2142 | 0.060 |
Why?
| | Gene Expression | 1 | 2009 | 1472 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 2058 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2008 | 466 | 0.050 |
Why?
| | Ryanodine | 2 | 2014 | 15 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2014 | 119 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 2832 | 0.050 |
Why?
| | Software | 1 | 2008 | 608 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 76 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2014 | 391 | 0.050 |
Why?
| | Disease Progression | 2 | 2021 | 2635 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1706 | 0.050 |
Why?
| | Portoenterostomy, Hepatic | 1 | 2021 | 45 | 0.050 |
Why?
| | Mitochondria | 2 | 2017 | 877 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 232 | 0.040 |
Why?
| | Teratoma | 1 | 2022 | 105 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 215 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2021 | 376 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1622 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 26 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2021 | 300 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 32 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 132 | 0.040 |
Why?
| | Astrocytoma | 1 | 2020 | 122 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 118 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 119 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 596 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4063 | 0.040 |
Why?
| | Gene Expression Regulation, Plant | 2 | 2009 | 55 | 0.040 |
Why?
| | Sulfonamides | 1 | 2022 | 496 | 0.040 |
Why?
| | Lysine | 1 | 2020 | 286 | 0.040 |
Why?
| | Cholic Acids | 1 | 2017 | 17 | 0.040 |
Why?
| | Chenodeoxycholic Acid | 1 | 2017 | 14 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 20 | 0.040 |
Why?
| | Mitochondrial Turnover | 1 | 2017 | 5 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 188 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 457 | 0.030 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 22 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 161 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2017 | 101 | 0.030 |
Why?
| | Feces | 1 | 2020 | 440 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2017 | 298 | 0.030 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 92 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 183 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 507 | 0.030 |
Why?
| | Longevity | 1 | 2017 | 151 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 345 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2017 | 111 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 429 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 835 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2781 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1245 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 613 | 0.030 |
Why?
| | Triglycerides | 1 | 2017 | 527 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 520 | 0.030 |
Why?
| | Carbachol | 1 | 2014 | 20 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1156 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 505 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1356 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1698 | 0.030 |
Why?
| | Ceruletide | 1 | 2012 | 4 | 0.030 |
Why?
| | Amylases | 1 | 2012 | 17 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2020 | 1902 | 0.030 |
Why?
| | Egtazic Acid | 1 | 2012 | 41 | 0.030 |
Why?
| | Chymotrypsin | 1 | 2012 | 19 | 0.030 |
Why?
| | Cell Death | 1 | 2014 | 354 | 0.030 |
Why?
| | Adenoviridae | 1 | 2013 | 192 | 0.020 |
Why?
| | Dantrolene | 1 | 2012 | 5 | 0.020 |
Why?
| | NFATC Transcription Factors | 1 | 2012 | 84 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 821 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 641 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2742 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4421 | 0.020 |
Why?
| | Cell Polarity | 1 | 2012 | 140 | 0.020 |
Why?
| | Tacrolimus | 1 | 2012 | 193 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2020 | 1171 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4083 | 0.020 |
Why?
| | Salicylic Acid | 1 | 2009 | 8 | 0.020 |
Why?
| | Female | 3 | 2021 | 68776 | 0.020 |
Why?
| | Plants, Genetically Modified | 1 | 2009 | 15 | 0.020 |
Why?
| | Plant Diseases | 1 | 2009 | 39 | 0.020 |
Why?
| | Dehydration | 1 | 2009 | 49 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2008 | 15 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 116 | 0.020 |
Why?
| | Droughts | 1 | 2009 | 42 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 653 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2679 | 0.020 |
Why?
| | Infant | 1 | 2021 | 9024 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 582 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2441 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6556 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 20393 | 0.010 |
Why?
|
|
Wang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|